Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

352.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.14m
  • Volume: 200,824
  • Market Cap: £373.60m
  • RiskGrade: 125
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
78.26% above the market average78.26% above the market average78.26% above the market average78.26% above the market average78.26% above the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
7.26% above the market average7.26% above the market average7.26% above the market average7.26% above the market average7.26% above the market average
12% below the sector average12% below the sector average12% below the sector average12% below the sector average12% below the sector average
Price Book Ratio
85.14% below the market average85.14% below the market average85.14% below the market average85.14% below the market average85.14% below the market average
48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
59.42% above the market average59.42% above the market average59.42% above the market average59.42% above the market average59.42% above the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Chg 3m
55.19% above the market average55.19% above the market average55.19% above the market average55.19% above the market average55.19% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
42.90% above the market average42.90% above the market average42.90% above the market average42.90% above the market average42.90% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Momentum 20
77.92% above the market average77.92% above the market average77.92% above the market average77.92% above the market average77.92% above the market average
80.95% above the sector average80.95% above the sector average80.95% above the sector average80.95% above the sector average80.95% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
64.33% below the market average64.33% below the market average64.33% below the market average64.33% below the market average64.33% below the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
95.81% below the market average95.81% below the market average95.81% below the market average95.81% below the market average95.81% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
28.33% above the market average28.33% above the market average28.33% above the market average28.33% above the market average28.33% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Operating Profit Loss
94.82% below the market average94.82% below the market average94.82% below the market average94.82% below the market average94.82% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
46.84% above the market average46.84% above the market average46.84% above the market average46.84% above the market average46.84% above the market average
53.49% above the sector average53.49% above the sector average53.49% above the sector average53.49% above the sector average53.49% above the sector average
Cash
57.81% above the market average57.81% above the market average57.81% above the market average57.81% above the market average57.81% above the market average
64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
41.18% below the market average41.18% below the market average41.18% below the market average41.18% below the market average41.18% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
49.11% below the market average49.11% below the market average49.11% below the market average49.11% below the market average49.11% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average
Brokers Percent Neutral
36.98% above the market average36.98% above the market average36.98% above the market average36.98% above the market average36.98% above the market average
Sector averageSector averageSector averageSector averageSector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 352.00p
Change Today -1.00p
% Change -0.28 %
52 Week High 445.00
52 Week Low 232.50
Volume 200,824
Shares Issued 106.14m
Market Cap £373.60m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.62% below the market average31.62% below the market average31.62% below the market average31.62% below the market average31.62% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Price Trend
32.31% below the market average32.31% below the market average32.31% below the market average32.31% below the market average32.31% below the market average
17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average
Income Not Available
Growth
2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
15:20 141 @ 354.00p
16:35 36,237 @ 352.00p
16:35 95 @ 352.00p
16:35 191 @ 352.00p
16:35 303 @ 352.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page